메뉴 건너뛰기




Volumn 62, Issue 6, 2010, Pages 678-684

Dynamic foams in topical drug delivery

Author keywords

Drug delivery; Dynamic; Foam; Topical; Vehicle

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; CORTICOSTEROID DERIVATIVE; SUNSCREEN; DRUG; EXCIPIENT;

EID: 77953557595     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.62.06.0003     Document Type: Review
Times cited : (48)

References (57)
  • 2
    • 0036886338 scopus 로고    scopus 로고
    • Patients with psoriasis prefer solution and foam vehicles: A quantitative assessment of vehicle preference
    • Housman TS et al. Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference. Cutis 2002 70: 327 332.
    • (2002) Cutis , vol.70 , pp. 327-332
    • Housman, T.S.1
  • 3
    • 33751225645 scopus 로고    scopus 로고
    • Emollient foam in topical drug delivery
    • Tamarkin D et al. Emollient foam in topical drug delivery. Expert Opin Drug Deliv 2006 3: 799 807.
    • (2006) Expert Opin Drug Deliv , vol.3 , pp. 799-807
    • Tamarkin, D.1
  • 4
    • 77953583915 scopus 로고    scopus 로고
    • The vehicle found in ketoconazole foam 2% is preferred by patients with mild to severe seborrheic dermatitis over other vehicles, regardless of gender, age, or ethnicity
    • Cash K, Quigley MO. The vehicle found in ketoconazole foam 2% is preferred by patients with mild to severe seborrheic dermatitis over other vehicles, regardless of gender, age, or ethnicity. J Am Acad Dermatol 2008 58: AB92.
    • (2008) J Am Acad Dermatol , vol.58 , pp. 92
    • Cash, K.1    Quigley, M.O.2
  • 5
    • 0038163576 scopus 로고    scopus 로고
    • The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions
    • Gottlieb AB et al. The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions. J Cutan Med Surg 2003 7: 185 192.
    • (2003) J Cutan Med Surg , vol.7 , pp. 185-192
    • Gottlieb, A.B.1
  • 6
    • 48249156924 scopus 로고    scopus 로고
    • Desonide: A review of formulations, efficacy and safety
    • Kahanek N et al. Desonide: a review of formulations, efficacy and safety. Expert Opin Investig Drugs 2008 17: 1097 1104.
    • (2008) Expert Opin Investig Drugs , vol.17 , pp. 1097-1104
    • Kahanek, N.1
  • 7
    • 47049092199 scopus 로고    scopus 로고
    • Desonide foam 0.05%: Safety in children as young as 3 months
    • Hebert AA. Desonide foam 0.05%: safety in children as young as 3 months. J Am Acad Dermatol 2008 59: 334 340.
    • (2008) J Am Acad Dermatol , vol.59 , pp. 334-340
    • Hebert, A.A.1
  • 8
    • 48749099907 scopus 로고    scopus 로고
    • Clobetasol propionate emulsion formulation foam 0.05%: Review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents
    • Kimball AB et al. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. J Am Acad Dermatol 2008 59: 448 454.
    • (2008) J Am Acad Dermatol , vol.59 , pp. 448-454
    • Kimball, A.B.1
  • 9
    • 0034853330 scopus 로고    scopus 로고
    • Betamethasone valerate foam for treatment of nonscalp psoriasis
    • Stein LF et al. Betamethasone valerate foam for treatment of nonscalp psoriasis. J Cutan Med Surg 2001 5: 303 307.
    • (2001) J Cutan Med Surg , vol.5 , pp. 303-307
    • Stein, L.F.1
  • 10
    • 17544362634 scopus 로고    scopus 로고
    • The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris
    • Shalita AR et al. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris. J Drugs Dermatol 2005 4: 48 56.
    • (2005) J Drugs Dermatol , vol.4 , pp. 48-56
    • Shalita, A.R.1
  • 11
    • 49649096627 scopus 로고    scopus 로고
    • Clobetasol propionate emollient formulation foam in the treatment of corticosteroid-responsive dermatoses
    • Frangos JE, Kimball AB. Clobetasol propionate emollient formulation foam in the treatment of corticosteroid-responsive dermatoses. Expert Opin Pharmacother 2008 9: 2001 2007.
    • (2008) Expert Opin Pharmacother , vol.9 , pp. 2001-2007
    • Frangos, J.E.1    Kimball, A.B.2
  • 12
    • 0036062441 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis
    • Lebwohl M et al. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis. Int J Dermatol 2002 41: 269 274.
    • (2002) Int J Dermatol , vol.41 , pp. 269-274
    • Lebwohl, M.1
  • 13
    • 20444461545 scopus 로고    scopus 로고
    • A novel foam vehicle for delivery of topical corticosteroids
    • Huang X et al. A novel foam vehicle for delivery of topical corticosteroids. J Am Acad Dermatol 2005 53: S26 S38.
    • (2005) J Am Acad Dermatol , vol.53
    • Huang, X.1
  • 14
    • 20444456597 scopus 로고    scopus 로고
    • Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis
    • Stein L. Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis. J Am Acad Dermatol 2005 53: S39 S49.
    • (2005) J Am Acad Dermatol , vol.53
    • Stein, L.1
  • 15
    • 34248999760 scopus 로고    scopus 로고
    • Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis
    • Mazzotta A et al. Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis. J Dermatol Treat 2007 18: 84 87.
    • (2007) J Dermatol Treat , vol.18 , pp. 84-87
    • Mazzotta, A.1
  • 16
    • 0032807315 scopus 로고    scopus 로고
    • Betamethasone valerate foam 0.12%: A novel vehicle with enhanced delivery and efficacy
    • Franz TJ et al. Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy. Int J Dermatol 1999 38: 628 632.
    • (1999) Int J Dermatol , vol.38 , pp. 628-632
    • Franz, T.J.1
  • 17
    • 0037238007 scopus 로고    scopus 로고
    • Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: An open, multicentre, randomized, controlled, cross-over study on 241 patients
    • Andreassi L et al. Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients. Br J Dermatol 2003 148: 134 138.
    • (2003) Br J Dermatol , vol.148 , pp. 134-138
    • Andreassi, L.1
  • 18
    • 0038607714 scopus 로고    scopus 로고
    • Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: A multicenter, prospective, randomized, controlled, investigator-blinded trial
    • Mancuso G et al. Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial. Int J Dermatol 2003 42: 572 575.
    • (2003) Int J Dermatol , vol.42 , pp. 572-575
    • Mancuso, G.1
  • 19
    • 0038005103 scopus 로고    scopus 로고
    • Efficacy of betamethasone valerate 0.1% thermophobic foam in seborrhoeic dermatitis of the scalp: An open-label, multicentre, prospective trial on 180 patients
    • Milani M et al. Efficacy of betamethasone valerate 0.1% thermophobic foam in seborrhoeic dermatitis of the scalp: an open-label, multicentre, prospective trial on 180 patients. Curr Med Res Opin 2003 19: 342 345.
    • (2003) Curr Med Res Opin , vol.19 , pp. 342-345
    • Milani, M.1
  • 20
    • 35148886772 scopus 로고    scopus 로고
    • A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men
    • Olsen EA et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol 2007 57: 767 774.
    • (2007) J Am Acad Dermatol , vol.57 , pp. 767-774
    • Olsen, E.A.1
  • 21
    • 84925559684 scopus 로고    scopus 로고
    • The treatment of hyperkeratosis with a new, 30% urea emollient foam: A series of case studies
    • Goldstein J, Gurge R. The treatment of hyperkeratosis with a new, 30% urea emollient foam: a series of case studies. J Am Acad Dermatol 2008 58: AB41.
    • (2008) J Am Acad Dermatol , vol.58 , pp. 41
    • Goldstein, J.1    Gurge, R.2
  • 22
    • 84925566661 scopus 로고    scopus 로고
    • Weaire, D. Hutzler, S. eds
    • Weaire D, Hutzler S, eds. The Physics of Foams.
    • The Physics of Foams.
  • 23
    • 20444482549 scopus 로고    scopus 로고
    • Foam drug delivery in dermatology: Beyond the scalp
    • Purdon CH et al. Foam drug delivery in dermatology: beyond the scalp. Am J Drug Deliv 2003 1: 71 75.
    • (2003) Am J Drug Deliv , vol.1 , pp. 71-75
    • Purdon, C.H.1
  • 25
    • 77953587701 scopus 로고    scopus 로고
    • Anon. In: Handbook for the Montreal Protocol on Substances That Deplete the Ozone Layer. 7th edn
    • Anon. Summary of control measures under the Montreal Protocol. In: Handbook for the Montreal Protocol on Substances That Deplete the Ozone Layer, 7th edn. 2006: 27 40.
    • (2006) Summary of Control Measures under the Montreal Protocol , pp. 27-40
  • 26
    • 0032790248 scopus 로고    scopus 로고
    • Drug-surfactant-propellant interactions in HFA-formulations
    • Vervaet C, Byron PR. Drug-surfactant-propellant interactions in HFA-formulations. Int J Pharm 1999 186: 13 30.
    • (1999) Int J Pharm , vol.186 , pp. 13-30
    • Vervaet, C.1    Byron, P.R.2
  • 27
    • 0034658554 scopus 로고    scopus 로고
    • Transition to CFC-free metered dose inhalers-into the new millennium
    • McDonald KJ, Martin GP. Transition to CFC-free metered dose inhalers-into the new millennium. Int J Pharm 2000 201: 89 107.
    • (2000) Int J Pharm , vol.201 , pp. 89-107
    • McDonald, K.J.1    Martin, G.P.2
  • 28
    • 84925569324 scopus 로고    scopus 로고
    • Polymers for the colloidal stabilization of drugs in HFAs
    • Wright P. Polymers for the colloidal stabilization of drugs in HFAs. RDD IV 2006 1: 243 248.
    • (2006) RDD IV , vol.1 , pp. 243-248
    • Wright, P.1
  • 29
    • 17644366769 scopus 로고    scopus 로고
    • Surfactant solubility and aggregate orientation in hydrofluoroalkanes
    • Ridder KB et al. Surfactant solubility and aggregate orientation in hydrofluoroalkanes. Int J Pharm 2005 295: 57 65.
    • (2005) Int J Pharm , vol.295 , pp. 57-65
    • Ridder, K.B.1
  • 36
    • 0021980791 scopus 로고
    • Foams in pharmacy
    • Pilpel N. Foams in pharmacy. Endeavour 1985 9: 87 91.
    • (1985) Endeavour , vol.9 , pp. 87-91
    • Pilpel, N.1
  • 39
    • 67349130576 scopus 로고    scopus 로고
    • Engineering novel topical foams using hydrofluroalkane emulsions stabilised with pluronic surfactants
    • Zhao Y et al. Engineering novel topical foams using hydrofluroalkane emulsions stabilised with pluronic surfactants. Eur J Pharm Sci 2009 37: 370 377.
    • (2009) Eur J Pharm Sci , vol.37 , pp. 370-377
    • Zhao, Y.1
  • 40
    • 14844329941 scopus 로고    scopus 로고
    • Experimental techniques for the characterization of foams
    • 1st edn. Prud'homme, R.K. Khan, S.A. eds
    • Wilson AJ. Experimental techniques for the characterization of foams. In Prud'homme RK, Khan SA, eds. Foams: Theory, Measurement and Applications, 1st edn.
    • Foams: Theory, Measurement and Applications
    • Wilson, A.J.1
  • 41
    • 0037439637 scopus 로고    scopus 로고
    • Perspectives on foam drainage and the influence of interfacial rheology
    • Stone HA et al. Perspectives on foam drainage and the influence of interfacial rheology. J Phys Condens Matter 2003 15: S283 S290.
    • (2003) J Phys Condens Matter , vol.15
    • Stone, H.A.1
  • 42
    • 41149124408 scopus 로고    scopus 로고
    • Aqueous foams: A field of investigation at the frontier between chemistry and physics
    • Langevin D. Aqueous foams: A field of investigation at the frontier between chemistry and physics. Chemphyschem 2008 9: 510 522.
    • (2008) Chemphyschem , vol.9 , pp. 510-522
    • Langevin, D.1
  • 44
    • 84925566661 scopus 로고    scopus 로고
    • Weaire, D. Hutzler, S. eds
    • Weaire D, Hutzler S eds. The Physics of Foams.
    • The Physics of Foams.
  • 45
    • 41549148681 scopus 로고    scopus 로고
    • The rheological properties of pharmaceutical foam: Implications for use
    • Kealy T et al. The rheological properties of pharmaceutical foam: implications for use. Int J Pharm 2008 355: 67 80.
    • (2008) Int J Pharm , vol.355 , pp. 67-80
    • Kealy, T.1
  • 46
    • 33750345304 scopus 로고    scopus 로고
    • Microscopic and thermodynamic properties of the HFA134a-water interface: Atomistic computer simulations and tensiometry under pressure
    • Peguin RPS et al. Microscopic and thermodynamic properties of the HFA134a-water interface: atomistic computer simulations and tensiometry under pressure. Langmuir 2006 22: 8826 8830.
    • (2006) Langmuir , vol.22 , pp. 8826-8830
    • Peguin, R.P.S.1
  • 47
    • 33750285649 scopus 로고    scopus 로고
    • Surfactant design for the 1,1,1,2-tetrafluoroethane-water interface: Ab initio calculations and in situ high-pressure tensiometry
    • Selvam P et al. Surfactant design for the 1,1,1,2-tetrafluoroethane-water interface: ab initio calculations and in situ high-pressure tensiometry. Langmuir 2006 22: 8675 8683.
    • (2006) Langmuir , vol.22 , pp. 8675-8683
    • Selvam, P.1
  • 48
    • 60849136012 scopus 로고    scopus 로고
    • Reverse aqueous emulsions and microemulsions in HFA227 propellant stabilized by non-ionic ethoxylated amphiphiles
    • Chokshi U et al. Reverse aqueous emulsions and microemulsions in HFA227 propellant stabilized by non-ionic ethoxylated amphiphiles. Int J Pharm 2009 369: 176 184.
    • (2009) Int J Pharm , vol.369 , pp. 176-184
    • Chokshi, U.1
  • 49
    • 0034039616 scopus 로고    scopus 로고
    • Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles
    • Feldman SR et al. Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles. J Am Acad Dermatol 2000 42: 1017 1020.
    • (2000) J Am Acad Dermatol , vol.42 , pp. 1017-1020
    • Feldman, S.R.1
  • 50
    • 20444461545 scopus 로고    scopus 로고
    • A novel foam vehicle for delivery of topical corticosteroids
    • Huang X et al. A novel foam vehicle for delivery of topical corticosteroids. J Am Acad Dermatol 2005 53: S26 S38.
    • (2005) J Am Acad Dermatol , vol.53
    • Huang, X.1
  • 56
    • 67449155891 scopus 로고    scopus 로고
    • A dynamic topical hydrofluoroalkane foam to induce nanoparticle modification and drug release in situ
    • Zhao Y et al. A dynamic topical hydrofluoroalkane foam to induce nanoparticle modification and drug release in situ. Eur J Pharm Biopharm 2009 72: 521 528.
    • (2009) Eur J Pharm Biopharm , vol.72 , pp. 521-528
    • Zhao, Y.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.